Also trades as: PHIA.AS (AMS) · $vol 44M · PHG (NYSE) · $vol 24M · PHI1.DE (XETRA) · $vol 0M · PHIA.DE (XETRA) · $vol 0M

$23.34

-1.71 (-6.81%)

Weekly Expected Move ±6.2%

$20 $22 $23 $25 $26

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 44 · $22.8B mcap · 795M float · 0.0002% daily turnover · Short 35% of daily vol

Revenue

$17.8B -1.1% ▼

5Y CAGR: -1.8%

Gross Profit

$8.1B +3.6% ▲

5Y CAGR: -1.7%

Operating Income

$1.6B +211.4% ▲

5Y CAGR: +1.3%

Net Income

$896M +227.6% ▲

5Y CAGR: -5.5%

EPS (Diluted)

$0.93 +224.0% ▲

5Y CAGR: -5.4%

EBITDA

$2.7B +13.9% ▲

5Y CAGR: -1.5%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$17.2B	$17.8B	$18.2B	$18.0B	$17.8B
YoY Growth	-12.2%	+3.9%	+1.9%	-0.8%	-1.1%
Cost of Revenue	$10.0B	$10.6B	$10.7B	$10.2B	$9.8B
Gross Profit	$7.2B	$7.2B	$7.4B	$7.8B	$8.1B
Gross Margin	41.8%	40.4%	41.0%	43.1%	45.2%
R&D Expenses	$1.8B	$2.1B	$1.9B	$1.7B	$1.7B
SG&A Expenses	$4.9B	$5.3B	$5.1B	$5.1B	$4.7B
Operating Expenses	$6.6B	$7.4B	$7.6B	$7.2B	$6.4B
Operating Income	$553M	-$1.5B	-$115M	$529M	$1.6B
Operating Margin	3.2%	-8.6%	-0.6%	2.9%	9.2%
Interest Expense	$188M	$244M	$306M	$337M	$346M
Income Before Tax	$509M	-$1.7B	-$527M	$123M	$1.2B
Tax Expense	-$103M	-$113M	-$73M	$963M	$282M
Net Income	$3.3B	-$1.6B	-$466M	-$702M	$896M
Net Margin	19.3%	-9.0%	-2.6%	-3.9%	5.0%
EPS (Diluted)	$3.49	$-1.68	$-0.50	$-0.75	$0.93
EBITDA	$2.0B	$115M	$1.0B	$2.3B	$2.7B
Shares Outstanding	950M	952M	925M	933M	963M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$4.4B	$5.0B	$4.1B	$4.3B	$4.3B	$5.1B	$3.9B	$4.4B
Cost of Revenue	$2.4B	$3.1B	$2.2B	$2.3B	$2.4B	$2.8B	$2.1B	$2.2B
Gross Profit	$2.0B	$2.0B	$1.8B	$2.0B	$1.9B	$2.3B	$1.8B	$2.1B
Gross Margin	45.8%	38.9%	45.1%	46.4%	44.4%	44.9%	45.2%	49.3%
R&D Expenses	$433M	$472M	$457M	$402M	$414M	$427M	$395M	$484M
SG&A Expenses	$1.2B	$1.3B	$1.2B	$1.2B	$1.2B	$1.3B	$1.2B	$1.2B
Operating Expenses	$1.7B	$1.8B	$1.7B	$1.6B	$1.6B	$1.6B	$1.6B	$1.5B
Operating Income	$337M	$199M	$154M	$400M	$330M	$763M	$210M	$610M
Operating Margin	7.7%	3.9%	3.8%	9.2%	7.7%	15.0%	5.4%	14.0%
Interest Expense	$104M	$51M	$82M	$80M	$57M	$109M	$83M	$95M
Income Before Tax	$246M	$116M	$105M	$337M	$275M	$466M	$191M	$546M
Tax Expense	$65M	$449M	$27M	$95M	$87M	$73M	$44M	$160M
Net Income	$181M	-$335M	$76M	$240M	$184M	$395M	$152M	$384M
Net Margin	4.1%	-6.6%	1.9%	5.5%	4.3%	7.7%	3.9%	8.8%
EPS (Diluted)	$0.19	$-0.36	$0.08	$0.25	$0.19	$0.41	$0.16	$0.40
EBITDA	$516M	$546M	$462M	$683M	$635M	$926M	$476M	$1.0B
Shares Outstanding	944M	929M	938M	957M	964M	966M	969M	969M

RYLPF OTC